A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)

Clinical trial NCT06721156 · TERMINATED

Trial details

NCT number: NCT06721156
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease Dementia

Start date: 2024-12-16
Primary completion: 2026-06-05
Enrollment: 369

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.